Skip to content

Gastric Electrical Stimulation for Abdominal Pain in Gastroparesis

Gastric Electrical Stimulation for Treating Abdominal Pain in Patients With Gastroparesis

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04121325
Enrollment
4
Registered
2019-10-09
Start date
2019-12-18
Completion date
2020-03-13
Last updated
2023-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Pain

Brief summary

To conduct a pilot study to evaluate the effects of new GES programming settings on abdominal pain in patients with gastroparesis and existing GES devices, whose abdominal pain has so far been refractory to drugs and/or devices.

Detailed description

Eligible patients will undergo detailed pain assessments as well as non-invasive physiologic assessment. Patients existing GES devices will be reprogrammed to new setting for 4 week and their GI symptoms including pain will be evaluated by a daily diary. At the end of 4 weeks detailed pain assessments and noninvasive physiologic assessments will be repeated.

Interventions

DEVICEEnterra

To measure validated and subjective pain scores among patients with an existing GES device, and who have a trial of new settings directed at abdominal pain and compare their pain scores to each patient baseline symptoms, done with their previous GES settings.

Sponsors

University of Louisville
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Should be able to give informed consent for the study * Has Enterra GES device in place for at least 2 months * Continue to have moderate to severe abdominal pain on at least one pain questionnaire or \>5 score (on a scale of 0-10 for pain) on the VAS questionnaire for at least 2 months. * Abdominal pain should be either persistent; for example, daily for at least \>1 hour, be chronic for \>2 months, and refractory to original Enterra GES settings

Exclusion criteria

* Unable to provide informed consent * Pregnancy * Any other active health problems that would render patient unable to complete the study

Design outcomes

Primary

MeasureTime frameDescription
Abdominal Pain4 weeksAbdominal Pain by Brief Pain Inventory. The values are 0-10, with 10 being worse outcome.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026